Total Muscle Coverage versus AlloDerm Human Dermal Matrix for Implant-Based Breast Reconstruction
- 1 January 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 143 (1), 1-6
- https://doi.org/10.1097/prs.0000000000005076
Abstract
Prosthetic breast reconstruction is the most common method for treatment of patients undergoing mastectomy. Acellular dermal matrix has become more popular in implant-based breast reconstruction. The authors conducted a retrospective review of all patients undergoing prosthetic breast reconstruction between August of 2002 and December of 2013. Patients were analyzed in terms of demographics, fill volumes, number of expansions, costs, and complications. A total of 284 patients underwent mastectomy surgery with 481 implant-based breast reconstructions. Four hundred eight tissue expanders had total muscle coverage, whereas 73 had AlloDerm. The rate of overall complications and major complications was significantly higher in the AlloDerm group: 20.5 percent versus 8.8 percent (p = 0.005), and 13.7 percent versus 5.1 percent (p = 0.0001), respectively. The mean initial fill volume was significantly lower in the total muscle coverage group compared to the acellular dermal matrix group (54 ± 47 versus 167 ± 139; p = 0.00003), resulting in a higher number of expansions (8.1 versus 5.8; p = 0.000051) and longer time to full expansion (60.2 days versus 43.3 days; p = 0.0002). This did not translate into a faster time to expander exchange (162.4 days versus 162.3 days; p = 0.13). Use of AlloDerm added a mean cost of $2217 for each breast. Implant-based breast reconstruction has evolved with the advent of acellular dermal matrices. Although the use of acellular dermal matrix allows increased initial fill volumes and fewer total expansions, there is an increased risk of complications and increased costs, especially in patients undergoing bilateral reconstruction. Total muscle coverage remains an excellent option for providing quality breast reconstruction without increased complications. Therapeutic, III.Keywords
This publication has 23 references indexed in Scilit:
- Use of Acellular Dermal Matrix in Postmastectomy Breast ReconstructionPlastic and Reconstructive Surgery, 2015
- ASPS Clinical Practice Guideline Summary on Breast Reconstruction with Expanders and ImplantsPlastic and Reconstructive Surgery, 2014
- The Use of Human Acellular Dermal Matrix in the First Stage of Implant-Based Breast Reconstruction Simplifies the Exchange ProcedurePlastic and Reconstructive Surgery, 2013
- A Paradigm Shift in U.S. Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- A Paradigm Shift in U.S. Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- The Influence of Sociodemographic Factors and Hospital Characteristics on the Method of Breast Reconstruction, Including MicrosurgeryPlastic and Reconstructive Surgery, 2012
- Comparison of Implant-Based Immediate Breast Reconstruction with and without Acellular Dermal MatrixPlastic and Reconstructive Surgery, 2011
- Implant-Based ReconstructionClinics in Plastic Surgery, 2007
- Immediate Bilateral Breast Reconstruction With Implants and Inferolateral AlloDerm SlingsAnnals of Plastic Surgery, 2005
- Mammary Reconstruction Using Tissue Expander and Partial Detachment of the Pectoralis Major Muscle to Expand the Lower Breast QuadrantsAnnals of Plastic Surgery, 2004